{"id":540938,"date":"2021-09-22T08:03:55","date_gmt":"2021-09-22T12:03:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/"},"modified":"2021-09-22T08:03:55","modified_gmt":"2021-09-22T12:03:55","slug":"rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/","title":{"rendered":"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWARK, Calif., Sept.  22, 2021  (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference being held virtually September 27-30, 2021.<\/p>\n<p>Additional details can be found below:<\/p>\n<p>\n        <strong>Date:<\/strong> Thursday, September 30, 2021<br \/><strong>Time:<\/strong> 10:00 a.m. ET<br \/><strong>Location:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UJSdJ6Zh2SJM4wAw4loBbYQO9UPtgbWLT0_qpWhgvd48gcYHbCmLqP9TbQcyd3gl1Y87SVDgCBkb41xJvXkAbiDtukEWuMFsYhIa3C-C2NabSgAdDAJhTGI5fD-2HyMnupy2W7W7roDSgDTbwt2cPMRJSHb1NvLs0sLBZi_UuesOHYCUsdP-f8AGk6JJ1K9fJ0xn0znS8-l5Gka9botAjw==\" rel=\"nofollow noopener\" target=\"_blank\">Webcast Link<\/a>  \u2013 or at the company\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m1hfczYfi4Wknw-mlfhvYVSiLCJftQoXRDe22nsSvS94JIoWu9djYSr48a2AmP50m03mjp-ekiOi_RGbfhASng==\" rel=\"nofollow noopener\" target=\"_blank\">click here<\/a>)<\/p>\n<p>A replay of the presentation will be available by visiting the &#8220;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rUGIXbSt4uQ1TLm_C-S-8jTVIlqKTBwGF-SgpV7XMrQlGNtgi0aSar3fTReUru0S6tMtMcLYcaErxrpNgFwRF-P4iEAK43bh6tQYxwcCf4Cs_exdfzpWhhUYdo7ERYkD5RFkS4JvZa-8O8xFOsJYKFcg2piMWQNKcNS1j1Ytch8=\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a>&#8221; section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days.<\/p>\n<p>\n        <strong>About Rain Therapeutics Inc.<\/strong><br \/>\n        <br \/>Rain Therapeutics Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors\u2019 underlying genetics rather than histology. Rain\u2019s lead product candidate, milademetan, is a small molecule, oral inhibitor of MDM2, which is oncogenic in numerous cancers. In addition to milademetan, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.<\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Jordyn Temperato<br \/>LifeSci Communications<br \/>+1.646.876.5196<br \/>jtemperato@lifescicomms.com<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDFmZTFhYWQtMzhmMi00YTEyLTk0NDUtNmE0NzVmM2NiZWQ3LTEyMTc3NTI=\/tiny\/Rain-Therapeutics-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWARK, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference being held virtually September 27-30, 2021. Additional details can be found below: Date: Thursday, September 30, 2021Time: 10:00 a.m. ETLocation:Webcast Link \u2013 or at the company\u2019s website (click here) A replay of the presentation will be available by visiting the &#8220;Events &amp; Presentations&#8221; section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days. About Rain Therapeutics Inc. Rain Therapeutics Inc. is a late-stage precision &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-540938","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWARK, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference being held virtually September 27-30, 2021. Additional details can be found below: Date: Thursday, September 30, 2021Time: 10:00 a.m. ETLocation:Webcast Link \u2013 or at the company\u2019s website (click here) A replay of the presentation will be available by visiting the &#8220;Events &amp; Presentations&#8221; section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days. About Rain Therapeutics Inc. Rain Therapeutics Inc. is a late-stage precision &hellip; Continue reading &quot;Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-22T12:03:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference\",\"datePublished\":\"2021-09-22T12:03:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/\"},\"wordCount\":223,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/\",\"name\":\"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=\",\"datePublished\":\"2021-09-22T12:03:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference - Market Newsdesk","og_description":"NEWARK, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference being held virtually September 27-30, 2021. Additional details can be found below: Date: Thursday, September 30, 2021Time: 10:00 a.m. ETLocation:Webcast Link \u2013 or at the company\u2019s website (click here) A replay of the presentation will be available by visiting the &#8220;Events &amp; Presentations&#8221; section of the Rain website after the conclusion of the presentation and will be archived on the Rain website for 30 days. About Rain Therapeutics Inc. Rain Therapeutics Inc. is a late-stage precision &hellip; Continue reading \"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-22T12:03:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference","datePublished":"2021-09-22T12:03:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/"},"wordCount":223,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/","name":"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=","datePublished":"2021-09-22T12:03:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTg2OCM0Mzg4MDQzIzIyMDYxOTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rain Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/540938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=540938"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/540938\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=540938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=540938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=540938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}